Dimensional Fund Advisors LP Buys Shares of 13,548 ReWalk Robotics Ltd. (NASDAQ:LFWD)

Dimensional Fund Advisors LP bought a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics at the end of the most recent reporting period.

Separately, Kent Lake Capital LLC acquired a new stake in ReWalk Robotics in the 1st quarter worth approximately $823,000. Institutional investors own 26.76% of the company’s stock.

Wall Street Analyst Weigh In

LFWD has been the subject of several analyst reports. HC Wainwright boosted their target price on ReWalk Robotics from $9.00 to $13.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Lake Street Capital upgraded ReWalk Robotics to a “strong-buy” rating in a report on Monday, June 24th.

ReWalk Robotics Stock Performance

LFWD opened at $2.65 on Wednesday. ReWalk Robotics Ltd. has a twelve month low of $2.55 and a twelve month high of $9.10. The firm has a market cap of $23.24 million, a P/E ratio of -0.87 and a beta of 2.02. The business has a 50 day moving average price of $3.26 and a 200 day moving average price of $4.08.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings results on Thursday, August 15th. The company reported ($0.50) EPS for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.03. ReWalk Robotics had a negative return on equity of 41.89% and a negative net margin of 102.03%. The company had revenue of $6.71 million during the quarter, compared to analyst estimates of $6.71 million. During the same period in the previous year, the company earned ($0.35) earnings per share. As a group, analysts anticipate that ReWalk Robotics Ltd. will post -1.65 earnings per share for the current fiscal year.

ReWalk Robotics Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.